Journal article
A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
Abstract
BACKGROUND: Ceftobiprole, the active moiety of ceftobiprole medocaril, is a novel broad-spectrum cephalosporin, with bactericidal activity against a wide range of gram-positive bacteria, including Staphylococcus aureus (including methicillin-resistant strains) and penicillin- and ceftriaxone-resistant pneumococci, and gram-negative bacteria, including Enterobacteriaceae and Pseudomonas aeruginosa.
METHODS: This was a double-blind, randomized, …
Authors
Awad SS; Rodriguez AH; Chuang Y-C; Marjanek Z; Pareigis AJ; Reis G; Scheeren TWL; Sánchez AS; Zhou X; Saulay M
Journal
Clinical Infectious Diseases, Vol. 59, No. 1, pp. 51–61
Publisher
Oxford University Press (OUP)
Publication Date
July 1, 2014
DOI
10.1093/cid/ciu219
ISSN
1058-4838